NCT01175733 - Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 8, 2010

Primary Completion Date

March 31, 2016

Study Completion Date

May 31, 2016

Conditions

Pancreatic Cancer

Interventions

DRUG

Panitumumab

During the first 6 weeks Panitumumab will be administered weekly in combination with radiotherapy plus gemcitabine. From week 8 and further gemcitabine will be administered as monotherapy until disease progression or unacceptable toxicity, for a maximum duration of 1 year.

Trial Locations (1)

1081HV

VU University Medical Center, Amsterdam